BCL2 and small cell lung carcinoma: These include 1) dysregulation of apoptosis linked to Bcl-2, 2) extracellular matrix (ECM)-mediated anti-apoptotic effects on SCLC cells, and 3) acquisition of cancer stem cell (CSC)-like properties.